Skip to content

Integra LifeSciences IART Specialty Surgery — Total Costs & Expenses

Similar metrics at other companies

Perrigo Company logo
PRGOSpecialty Care — Total Operating Expenses
$58.9M-21.4%
Cardinal Health logo
CAHPharmaceutical and Specialty Solutions — Total Costs & Expenses
$55.33B+11.2%
APi Group logo
APGSpecialty Services — Segment operating expenses
$67M+8.1%
Envista Holdings Corporation logo
NVSTSpecialty Products & Technologies — Expenses
$411.3M+13.4%
Perrigo Company logo
PRGOSpecialty Care — Cost of Sales
$92.8M+13.0%
Balchem logo
BCPCSpecialty Products — Operating Expenses
$8.53M+10.7%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's specialty surgery — total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's specialty surgery — total costs & expenses?
Integra LifeSciences (IART) reported specialty surgery — total costs & expenses of $200.01M in Q1 2026.
What does specialty surgery — total costs & expenses mean?
This represents the aggregate of all operating costs, including cost of goods sold, R&D, and SG&A, incurred by the Specialty Surgery segment. It provides a comprehensive view of the total expenditure required to sustain the segment's operations and revenue generation.